mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.1 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.44 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.1 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |